Odulimomab

DB33650ExperimentalProtein Based Therapies

Odulimomab: Overview.

Code names
Afolimomab ยท anti-LFA1

Resolves to

Compound
UNII39R9XU694MChEMBLCHEMBL2109177

Which companies are running trials of Odulimomab, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In